LIPID METABOLISM ENZYMES

• Main Authors: WALIA, NARINDER, K, HAFALIA, APRIL, KHAN, FARRAH, A, HILLMAN, JENNIFER, L, TRIBOULEY, CATHERINE, M, TANG, Y., TOM, POLICKY, JENNIFER, L, NGUYEN, DANNIEL, B, DAS, DEBOPRIYA, YAO, MONIQUE, G, YUE, HENRY, GANDHI, AMEENA, R, LAL, PREETI
• Format: Patent
• Language: English; French
• Published: 06.06.2002
• Edition: 7
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; COMPOSITIONS THEREOF; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME. L'invention porte sur des enzymes humaines métabolisant les lipides (LME) et sur des polynucléotides identifiant lesdites enzymes et codant pour elles. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes, ainsi que sur des procédés de diagnostic, traitement ou prévention de troubles associés à une expression aberrante de LME.